Stock listing
NASDAQ:KLRS Kalaris Therapeutics, Inc. Stock
Home listing (NASDAQ) of Kalaris Therapeutics, Inc.
Follow Kalaris Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:KLRS
$2.00 USD -0.03 (-1.5%)
Close on Nov 2, 2026
- Day range
- $1.92 – $2.06 USDNov 2, 2026
- Volume
- 59,274 sharesNov 2, 2026
- Market cap
- $47.61M USDAt the close on Nov 2, 2026 · price × 23.80M shares outstanding
- 52-week range
- $1.78 – $11.88 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $211,518 USDMedian day 57,000 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KLRS · Home | $2.00 USD | -0.03 (-1.5%) | 59,274 | $2.06 | $2.06 | $1.92 | $2.03 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:KLRS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.00 | -0.03 | -1.5% | $2.06 | $2.06 | $1.92 | 59,274 | |
| $2.03 | -0.10 | -4.7% | $1.98 | $2.08 | $1.965 | 60,195 | |
| $2.13 | +0.12 | +6.0% | $2.05 | $2.161 | $2.05 | 23,166 | |
| $2.01 | +0.15 | +8.1% | $1.86 | $2.02 | $1.86 | 47,608 | |
| $1.86 | +0.06 | +3.3% | $1.78 | $1.875 | $1.78 | 50,126 | |
| $1.80 | -0.07 | -3.7% | $1.90 | $1.90 | $1.78 | 36,033 | |
| $1.87 | -0.12 | -6.0% | $1.99 | $1.99 | $1.87 | 25,400 | |
| $1.99 | -0.03 | -1.5% | $2.01 | $2.04 | $1.95 | 43,400 | |
| $2.02 | -0.05 | -2.4% | $2.00 | $2.182 | $1.95 | 84,400 | |
| $2.07 | +0.16 | +8.4% | $1.90 | $2.10 | $1.90 | 51,400 | |
| $1.91 | -0.09 | -4.5% | $2.04 | $2.04 | $1.867 | 271,500 | |
| $2.00 | -0.19 | -8.7% | $2.25 | $2.292 | $2.00 | 58,400 | |
| $2.19 | +0.06 | +2.8% | $2.20 | $2.225 | $2.10 | 57,000 | |
| $2.13 | -0.10 | -4.5% | $2.22 | $2.23 | $2.11 | 21,000 | |
| $2.23 | -0.03 | -1.3% | $2.27 | $2.295 | $2.20 | 73,300 | |
| $2.26 | -0.10 | -4.2% | $2.37 | $2.37 | $2.22 | 122,100 | |
| $2.36 | -0.14 | -5.6% | $2.46 | $2.55 | $2.36 | 104,400 | |
| $2.50 | -0.06 | -2.3% | $2.60 | $2.60 | $2.35 | 110,000 | |
| $2.56 | -0.10 | -3.8% | $2.59 | $2.693 | $2.53 | 74,100 | |
| $2.66 | -0.17 | -6.0% | $2.90 | $2.93 | $2.61 | 103,400 | |
| $2.83 | +0.13 | +4.8% | $2.72 | $2.89 | $2.58 | 27,400 | |
| $2.70 | -0.15 | -5.3% | $2.90 | $2.90 | $2.51 | 235,900 | |
| $2.85 | -0.04 | -1.4% | $2.88 | $2.89 | $2.76 | 58,600 | |
| $2.89 | -0.01 | -0.3% | $2.87 | $2.97 | $2.75 | 102,600 | |
| $2.90 | +0.055 | +1.9% | $2.84 | $2.91 | $2.835 | 51,800 | |
| $2.845 | -0.075 | -2.6% | $2.91 | $2.97 | $2.81 | 92,800 | |
| $2.92 | -0.15 | -4.9% | $3.024 | $3.09 | $2.91 | 49,300 | |
| $3.07 | -0.05 | -1.6% | $3.13 | $3.162 | $3.02 | 33,600 | |
| $3.12 | -0.12 | -3.7% | $3.20 | $3.21 | $3.12 | 24,000 | |
| $3.24 | -0.005 | -0.2% | $3.225 | $3.285 | $3.16 | 29,100 | |
| $3.245 | +0.045 | +1.4% | $3.20 | $3.30 | $3.09 | 88,600 | |
| $3.20 | +0.04 | +1.3% | $3.18 | $3.23 | $3.04 | 234,400 | |
| $3.16 | -0.02 | -0.6% | $3.20 | $3.27 | $3.13 | 43,300 | |
| $3.18 | -0.02 | -0.6% | $3.15 | $3.25 | $3.10 | 61,700 | |
| $3.20 | -0.10 | -3.0% | $3.35 | $3.355 | $3.20 | 109,400 | |
| $3.30 | -0.08 | -2.4% | $3.41 | $3.445 | $3.25 | 57,600 | |
| $3.38 | +0.08 | +2.4% | $3.39 | $3.44 | $3.27 | 95,100 | |
| $3.30 | -0.17 | -4.9% | $3.55 | $3.66 | $3.30 | 60,700 | |
| $3.47 | -0.16 | -4.4% | $3.66 | $3.68 | $3.45 | 83,000 | |
| $3.63 | -0.27 | -6.9% | $3.88 | $3.90 | $3.60 | 100,700 | |
| $3.90 | -0.04 | -1.0% | $3.91 | $3.95 | $3.82 | 23,900 | |
| $3.94 | +0.04 | +1.0% | $3.97 | $4.04 | $3.905 | 40,000 | |
| $3.90 | -0.02 | -0.5% | $3.97 | $4.135 | $3.90 | 16,400 | |
| $3.92 | -0.12 | -3.0% | $3.96 | $4.00 | $3.86 | 62,300 | |
| $4.04 | +0.01 | +0.2% | $3.99 | $4.04 | $3.83 | 19,600 | |
| $4.03 | -0.07 | -1.7% | $4.12 | $4.15 | $3.89 | 52,600 | |
| $4.10 | +0.02 | +0.5% | $4.08 | $4.19 | $4.00 | 104,900 | |
| $4.08 | -0.12 | -2.9% | $4.24 | $4.31 | $3.99 | 28,200 | |
| $4.20 | +0.10 | +2.4% | $4.04 | $4.25 | $4.04 | 26,300 | |
| $4.10 | -0.05 | -1.2% | $4.13 | $4.19 | $3.94 | 51,400 | |
| $4.15 | +0.03 | +0.7% | $4.10 | $4.305 | $3.99 | 81,200 | |
| $4.12 | -0.05 | -1.2% | $4.20 | $4.20 | $3.97 | 50,200 | |
| $4.17 | +0.14 | +3.5% | $4.10 | $4.33 | $3.98 | 79,500 | |
| $4.03 | +0.07 | +1.8% | $4.00 | $4.20 | $3.89 | 29,500 | |
| $3.96 | -0.12 | -2.9% | $4.05 | $4.17 | $3.912 | 30,100 | |
| $4.08 | +0.20 | +5.2% | $4.02 | $4.15 | $3.88 | 28,100 | |
| $3.88 | -0.06 | -1.5% | $3.92 | $4.06 | $3.84 | 56,500 | |
| $3.94 | -0.03 | -0.8% | $4.07 | $4.18 | $3.936 | 62,200 | |
| $3.97 | +0.03 | +0.8% | $3.95 | $4.14 | $3.94 | 27,400 | |
| $3.94 | -0.13 | -3.2% | $4.14 | $4.17 | $3.89 | 40,100 | |
| $4.07 | -0.12 | -2.9% | $4.27 | $4.31 | $4.04 | 58,800 | |
| $4.19 | 0.00 | 0.0% | $4.19 | $4.305 | $4.095 | 55,600 | |
| $4.19 | -0.13 | -3.0% | $4.32 | $4.38 | $4.062 | 26,400 | |
| $4.32 | +0.27 | +6.7% | $4.02 | $4.40 | $4.02 | 133,400 | |
| $4.05 | +0.54 | +15.4% | $3.57 | $4.085 | $3.46 | 156,600 |
- Ticker
- NASDAQ:KLRS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Aug 31, 2026
Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 56 slides
Latest news
Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference
Aug 31, 2026
Closed $4.04 (+0.2%) on Aug 31, 2026
Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer
Jul 20, 2026
Closed $4.00 (-8.7%) on Jul 20, 2026
Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts
Jul 17, 2026
Closed $4.38 (-5.0%) on Jul 17, 2026
Kalaris Appoints Laurie Keating to Board of Directors
Jul 6, 2026
Closed $4.83 (+3.9%) on Jul 7, 2026
Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling
Jun 23, 2026
Closed $4.47 (+1.6%) on Jun 23, 2026
Kalaris to Present at Clinical Trials at the Summit 2026
Jun 12, 2026
Closed $4.33 (-0.7%) on Jun 12, 2026
Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates
May 12, 2026
Closed $4.79 (+1.3%) on May 12, 2026
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
Mar 17, 2026
Closed $8.52 (-3.3%) on Mar 17, 2026
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
Jan 28, 2026
Closed $9.20 (-2.6%) on Jan 29, 2026
Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
Dec 17, 2025
Closed $10.42 (0.0%) on Dec 18, 2025
Decks
Investor Presentation (September 2026)
Investor deck · 56 slides · September 2026
Investor Presentation (July 2026)
Investor deck · 57 slides · Jul 17, 2026
Investor Presentation (March 2026)
Investor deck · 58 slides · Mar 9, 2026
Technical Presentation (December 2025)
Technical · 30 slides · Dec 17, 2025
Kalaris Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 48 in all · newest Aug 31, 2026 · oldest 2022
- Decks
- 8 decks · latest September 2026
Where Kalaris Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KLRS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:KLRS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Kalaris Therapeutics, Inc.